Does timing matter on tocilizumab administration? Clinical, analytical and radiological outcomes in COVID-19

INTRODUCTION: While there are no pharmacological treatments with proven efficacy for coronavirus disease 2019 (COVID-19), tocilizumab has emerged as a candidate therapy. Some aspects of this therapy are still unknown, including the optimal timing of administration. OBJECTIVE: This observational stud...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Eur J Hosp Pharm
Hlavní autoři: Moreno Diaz, Raquel, Amor García, Miguel Angel, Teigell Muñoz, Francisco Javier, Saldaña Perez, Leonardo Ernesto, Mateos Gonzalez, María, Melero Bermejo, Jose Antonio, López Hernández, Alberto, Reyes Marquez, Laura, De Guzman García-Monge, Maria Teresa, Perez Quero, Jose Luis, Homez Guzman, Marcela Patricia
Médium: Artigo
Jazyk:Inglês
Vydáno: BMJ Publishing Group 2022
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7907834/
https://ncbi.nlm.nih.gov/pubmed/33627476
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2020-002669
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky